Stryker to acquire Entellus Medical for $662 million

Stryker Corporation announced a definitive merger agreement to acquire Entellus Medical for $24.00 per share, or an equity value of approximately $662 million. Entellus is a medical technology company focused on ENT products.

“Stryker Corporation announced today a definitive merger agreement to acquire Entellus Medical, Inc. for $24.00 per share, or an equity value of approximately $662 million.”investors.stryker.com

• 1 source
• investors.stryker.comStryker - Stryker announces definitive agreement to acquire EntellusDec 7, 2017

Summarized from public sources; check the original articles before acting on it.